Daily Archives: February 14, 2012

Warning and NOV Letter Summary – 4th Quarter 2011

Each quarter Eye on FDA provides a brief recap of the regulatory action letters issued respecting the promotion of prescription drugs. The office that issues the letter underwent a change during 2011, changing its name in the process from the … Continue reading

Posted in Warning Letters | Comments Off